Skip to main content
Cloudy icon
40º
Join Insider

HEALTH

Michigan Medicine $7 million in funding for COVID-19 therapy trial

Tags: university of michigan, good health, ann arbor, clinical trial, medical university of south carolina, lung, convalescent plasma, stanford medicine, covid-19 cases, health, coronavirus, covid-19, emergency department, and blood institute, michigan medicine, study, michigan, national heart, university of pittsburgh, mild cases, Ann Arbor, Michigan, University Of Michigan, Convalescent Plasma, Michigan Medicine, Coronavirus, COVID-19, Health, National Heart, Lung, And Blood Institute, University Of Pittsburgh, Medical University Of South Carolina, Stanford Medicine, Emergency Department, Mild Cases, COVID-19 Cases, Study, Clinical Trial, Good Health

Researchers at the University of Michigan’s Michigan Medicine and three other medical centers were awarded a total of $7 million from the National Heart, Lung, and Blood Institute (NHBLI) to study convalescent plasma in reducing symptoms of COVID-19 in patients with mild cases, Michigan Medicine announced Thursday.

MORE VIDEOS